期刊文献+

深圳市2008--2009年A型H1N1季节性流感病毒神经氨酸酶抑制剂耐药性监测 被引量:5

Surveillance for neuraminidase inhibitor resistance of seasonal H1N1 influenza A viruses isolated in Shenzhen during 2008 to 2009
原文传递
导出
摘要 目的对深圳市2008--2009年分离到的H1N1季节性流感病毒神经氨酸酶(NA)抑制剂的耐药性进行监测。方法根据原始临床样本的采集时间,按周抽取了55株2008--2009年分离到的H1N1季节性流感病毒,对其NA片段进行全长测序,选取WHO推荐的疫苗株和部分国内外分离到的ⅢN1季节性流感病毒作为参考株,运用Mega3.1软件进行种系发生树的构建、耐药相关位点及糖基化位点的分析。结果对NA片段的序列分析发现2008年有2株(7.1%)出现了H275Y突变,但是2009年则有25株(92.6%)出现了该突变。提示H275Y达菲耐药突变株成为了2009年深圳市社区传播的优势株。同时还发现了一株Q136K变异株,显示对乐感清出现耐药。分子进化分析结果显示,H275Y变异成为了毒株在系统进化树上分布的主要依据。所有的深圳株NA片段上潜在的糖基化位点序列保守。结论大量H275Y达菲耐药株的出现提示在今后的工作中应当密切关注流感病毒的耐药进展,进一步加强其耐药机制的研究。 Objective To analyze neuraminidase (NA) inhibitor resistance of seasonal H1 N1 influenza A viruses isolated in Shenzhen during 2008 to 2009. Methods The NA gene of these viruses were sequenced. Phylogenetic analysis of the sequences was performed with Mega3. 1 software. Results In 2008, most isolates of the seasonal H1N1 virus were susceptible to neuraminidase inhibitors, but the H275Y mutation in the neuraminidase gene region associated with high-level osehamivir resistance had been detected in 92.6% of the strains isolated in 2009. Furthermore, a strain with Q136K was found, which showed the resistance to Zanamivir. Conclusion In the light of emerging resistance, close monitoring and understanding of the nature and dynamics of resistance mutations in influenza virus should be a priority.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2011年第7期609-612,共4页 Chinese Journal of Microbiology and Immunology
基金 深圳市科技计划项目(200903123)
关键词 H1N1 神经氨酸酶抑制剂 耐药 H1N1 Neuraminidase inhibitor Resistant
  • 相关文献

参考文献9

  • 1徐红,钱渊,许航,张家淮,朱汝南,王芳.甲3型流感病毒流行株金刚烷胺耐药性的初步研究[J].中华医学杂志,2006,86(14):996-998. 被引量:6
  • 2Bright RA, Medina M J, Xu X, et al. Incidence of adamantane resistance among influenza A (H3 N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet, 2005, 366(9492) : 1175-1181.
  • 3Deyde VM, Xu X, Bright RA, et 8.l. Surveillance of resistance to adamantanes among influenza A(H3N2) and A( H1N1 ) viruses isolated worldwide. J Infect Dis, 2007, 196(2) : 249-257.
  • 4Moscona A. Oseltamivir resistance : disabling our influenza defen- ses. N Engl J Med, 2005, 353(25) : 2633-2636.
  • 5Meijer A, Lackenby A, Hungnes O, et al. Oseltamivir-resistant influenza virus A ( H1 N1 ) Europe, 2007-2008 season. Emerg In- fect Dis, 2009, 15(4) : 552-560.
  • 6Baranovich T, Saito R, Suzuki Y, et al. Emergence of H274Y oseltamivir-resistant A( HIN1 ) influenza viruses in Japan during the 2008-2009 season. J Clin Virol, 2010, 47(1) : 23-28.
  • 7苏彤,李淑华,鹿文英,韩磊,韩一芳,曹广文.一株新型甲型H1N1流感病毒H275Y的奥司他韦耐药变异分析[J].解放军医学杂志,2009,34(12):1412-1418. 被引量:10
  • 8Hurt AC, Holien JK, Parker M, et al. Zanamivir-resistant influ- enza viruses with a novel neuraminidase mutation. J Virol, 2009, 83(20) : 10366-10373.
  • 9Sheu TG, Deyde VM, Okomo-Adhiambo M, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimi- crob Agents Chemother, 2008, 52(9) : 3284-3292.

二级参考文献31

  • 1Colman PM, Hoyne PA, Lawrence MC. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J Virol, 1993, 67(6): 2972.
  • 2Colman PM, Varghese JN, Laver WG. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature, 1983, 303 (5912) : 41.
  • 3Yen HL, Ilyushina NA, Salomon R, et al. Neuraminidase inhibitorresistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol, 2007, 81(22): 12418.
  • 4Meijer A, Laekenby A, Hungnes O, et al. Oseltamivir-resistant influenza virus A (HIN1), Europe, 2007-08 season. Emerg Infect Dis, 2009, 15(4): 552.
  • 5Mossong J, Opp M, Gerloff N, et al. Emergence of osehamivir-resistant influenza A H1N1 virus during the 2007-2008 winter season in Luxembourg: clinical characteristics and epidemiology. Antiviral Res, 2009, 84(1): 91.
  • 6Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 2009, 325(5937): 197.
  • 7Ferraris O, Lina B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol, 2008, 41(1) : 13.
  • 8Hurt AC, Ernest J, Deng YM, et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res, 2009, 83(1): 90.
  • 9Gooskens J, Jonges M, Claas EC, et al. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influen za A(H1N1) virus JAMA, 2009, 301(10): 1042.
  • 10Dharan NJ, Gubareva LV, Meyer J J, et al. Infections with oseltamivir resistant influenza A(H1N1) virus in the United States. JAMA, 2009, 301(10): 1034.

共引文献14

同被引文献59

  • 1钱方.神经氨酸酶抑制剂在对抗流感病毒中的作用[J].医药论坛杂志,2006,27(23):124-125. 被引量:4
  • 2GILLIAN M A, LAVER W G. The neuraminidase of influenza vires [ J ]. Structure, Function, and Genetics, 1989, 6:341 - 356 .
  • 3PRATIP S, SAMEER S C, SARAH S C. Antigenic variability in neuraminidase protein of influenza A/H3N2 vaccine strains ( 1968 -2009) [J]. Bioinformation,2011, 7(2) : 76 -81.
  • 4XAVIER D, SYLVIE V, THIERRY B, et al. Efficacy of oseha- mivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial [ J ]. PLoS Medicine ,2010,7 : 11.
  • 5FERRARIS O, LINA B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance [ J ]. Clin Virol, 2008,41 (1) :13 -19.
  • 6SHAILENDRA K S, NIRAJ M, RAKHI S ,et al. Structural and antigenic variance between novel izffluenza A/H1 N1/2009 and in- fluenza A/H1 N1/2008 viruses [ J ]. J Infect Dev Ctries, 2010,4 (1):1-6.
  • 7YEN H L, HOFFMANN E, TAYLOR G, et al. hnportance of neuraminidase active site residues to the neuraminidase inhibitor resistance of influenza viruses [ J ]. Journal of Virology, 2006,80 (17) :8787 -8795.
  • 8MCKIMM-BRESCHKIN J, TRIVEDI T, HAMPSON A. Neura- minidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir [ J ].Antimicrob Agents Chemother, 2003,47 ( 7 ) :2264 - 2272.
  • 9BARANOVICH T, SAITO R , SUZUKI Y . Emergence of H274Y osehamivir-resistant A ( H1 N1 ) influenza viruses in Japan during the 2008 - 2009 season[ J]. Journal of Clinical Virology,2010,1(47) :23 -28.
  • 10Lan Y,Zhang Y,Dong L. A comprehensive surveillance of adamantane resistance among human influenza A virus isolated from China's Mainland between 1956 and 2009[J].{H}Antiviral Therapy,2010.853-859.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部